| Literature DB >> 24911008 |
Suvi-Päivikki Sinikumpu1, Laura Huilaja1, Jari Jokelainen2, Markku Koiranen3, Juha Auvinen3, Päivi M Hägg1, Erika Wikström1, Markku Timonen3, Kaisa Tasanen1.
Abstract
To determine the overall prevalence of skin diseases a whole-body skin examination was performed for 1,932 members (46-years of age) of the Northern Finland Birth Cohort (NFBC 1966), which is a comprehensive longitudinal research program (N = 12,058). A high prevalence of all skin diseases needing treatment was found (N = 1,158). Half of the cases of skin findings were evaluated to be serious enough to require diagnostic evaluation, treatment or follow-up either in a general health care, occupational health care or a secondary care setting. The remaining half were thought to be slight and self-treatment was advised. Males (70%) had more skin diseases needing treatment than females (52%) (P<0.001). The most common skin finding was a benign skin tumor, which was found in every cohort member. Skin infections (44%), eczemas (27%) and sebaceous gland diseases (27%) were the most common skin diseases in the cohort. Moreover, skin infections and eczemas were more commonly seen in the group with low education compared to those with high education (P<0.005). The results strengthen the postulate that skin diseases are common in an adult population.Entities:
Mesh:
Year: 2014 PMID: 24911008 PMCID: PMC4049840 DOI: 10.1371/journal.pone.0099533
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the study population and the classification of need of treatment according to found skin disease.
| Total | Male | Female | ||
| N = 1930 | N = 894 (46.3%) | N = 1036 (53.7%) | ||
| n (%) | n (%) | n (%) |
| |
|
| 0.036 | |||
| Married/cohabitant | 1465 (78.3) | 689 (79.7) | 776 (77.1) | |
| Single | 396 (21.2) | 175 (20.2) | 221 (22.0) | |
| Widower/widow | 10 (0.5) | 1 (0.1) | 9 (0.9) | |
|
| 0.149 | |||
| Basic (9 years) | 54 (2.8) | 30 (3.4) | 24 (2.3) | |
| Secondary (10–12 years) | 1130 (58.6) | 535 (59.8) | 595 (57.4) | |
| Tertiary (over 13 years) | 746 (38.7) | 329 (36.8) | 417 (40.3) | |
|
| <0.001 | |||
| None | 649 (33.6) | 218 (24.4) | 431 (41.6) | |
| 1 | 688 (35.7) | 328 (36.7) | 360 (34.8) | |
| 2 | 372 (19.3) | 203 (22.7) | 169 (16.3) | |
| 3 | 151 (7.8) | 96 (10.7) | 55 (5.3) | |
| 4 or more | 70 (3.6) | 49 (5.5) | 21 (2.0) | |
|
| <0.001 | |||
| No need of care | 772 (40.0) | 270 (30.3) | 502 (48.5) | |
| Need a self-treatment | 646 (33.5) | 347 (38.9) | 299 (28.9) | |
| Need care by a general practioner | 472 (24.5) | 256 (28.7) | 216 (20.8) | |
| Need care in a special health care | 38 (2.0) | 19 (2.1) | 19 (1.8) |
*Pearson's Chi-Squared test or Fisher's Exact test.
Basic education (comprehensive schools), secondary level (upper secondary schools, vocational schools), tertiary level (universities, polytechnics).
Skin findings which did not require treatment are excluded (for example benign skin tumors, androgenetic alopecia and erytematoteleangiectatic rosacea).
Prevalences of found skin diseases and skin findings in the study population, their total numbers and distribution by sex.
| Total | Male | Female | ||
| % (n) | % (n) | % (n) |
| |
|
| 1930 (100) | 894 (100) | 1036 (100) | |
| Pigmented naevus, >50 nevi | 222 (11.5) | 116 (13.0) | 106 (10.2) | 0.060 |
| Granuloma pyogenicum | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Blue naevus | 26 (1.3) | 8 (0.9) | 18 (1.7) | 0.109 |
| Naevus spilus | 90 (4.7) | 39 (4.4) | 51 (4.9) | 0.561 |
| Halo naevus | 16 (0.8) | 7 (0.8) | 9 (0.9) | 0.836 |
| Dermatofibroma | 428 (22.2) | 155 (17.3) | 273 (26.4) | <0.001 |
| Cherry angioma | 1158 (60.0) | 476 (53.2) | 682 (65.9) | <0.001 |
| Keloid | 52 (2.7) | 24 (2.7) | 28 (2.7) | 0.980 |
| Seborrheic keratosis | 855 (44.3) | 366 (40.9) | 489 (47.2) | 0.006 |
| Lentigo senilis | 262 (13.6) | 90 (10.1) | 172 (16.6) | <0.001 |
| Lipoma | 61 (3.2) | 41 (4.6) | 20 (1.9) | <0.001 |
| Congenital melanocytic naevus | 78 (4.0) | 44 (4.9) | 34 (3.3) | 0.068 |
| Naevus flammeus | 495 (25.6) | 195 (21.8) | 300 (29.0) | <0.001 |
| Cafe au lait spot | 240 (12.4) | 107 (12.0) | 133 (12.8) | 0.564 |
|
| 840 (43.5) | 483 (54.0) | 357 (34.5) | <0.001 |
| Pityriasis versicolor | 38 (2.0) | 19 (2.1) | 19 (1.8) | 0.646 |
| Onychomycosis | 181 (9.4) | 126 (14.1) | 55 (5.3) | <0.001 |
| Tinea pedis | 517 (26.8) | 327 (36.6) | 190 (18.3) | <0.001 |
| Tinea corporis | 8 (0.4) | 4 (0.4) | 4 (0.4) | 0.834 |
| Folliculitis | 116 (6.0) | 86 (9.6) | 30 (2.9) | <0.001 |
| Pyoderma | 1 (0.1) | 0 (0.0) | 1 (0.1) | 0.353 |
| Verruca plantaris | 179 (9.3) | 76 (8.5) | 103 (9.9) | 0.277 |
| Verruca palmaris | 51 (2.6) | 22 (2.5) | 29 (2.8) | 0.644 |
|
| 515 (26.7) | 210 (23.5) | 305 (29.4) | 0.003 |
| Acne vulgaris | 152 (7.9) | 66 (7.4) | 86 (8.3) | 0.451 |
| Comedo acne | 26 (1.3) | 8 (0.9) | 18 (1.7) | 0.109 |
| Papulopustular acne | 130 (6.7) | 64 (7.2) | 66 (6.4) | 0.495 |
| Cystic acne | 8 (0.4) | 4 (0.4) | 4 (0.4) | 0.836 |
| Acne scars | 188 (9.8) | 103 (11.5) | 85 (8.2) | 0.015 |
| Rosacea | 292 (15.1) | 94 (10.5) | 198 (19.1) | <0.001 |
| Erytematoteleangiectatic | 242 (12.6) | 78 (8.7) | 164 (15.9) | <0.001 |
| Papulopustular | 45 (2.3) | 12 (1.3) | 33 (3.2) | 0.007 |
| Phymatotic | 3 (0.2) | 3 (0.3) | 0 (0.0) | 0.062 |
| Ocular | 1 (0.1) | 0 (0.0) | 1 (0.1) | 0.352 |
| Perioraldermatitis | 14 (0.7) | 1 (0.1) | 13 (1.3) | 0.003 |
|
| 563 (29.2) | 295 (33.0) | 268 (25.9) | <0.001 |
| Eczemas | 528 (27.4) | 277 (31.0) | 251 (24.2) | <0.001 |
| Atopic eczema | 93 (4.8) | 35 (3.9) | 58 (5.6) | 0.084 |
| Hand eczema | 171 (8.9) | 66 (7.4) | 105 (10.1) | 0.033 |
| Seborrheic eczema | 141 (7.3) | 108 (12.1) | 33 (3.2) | <0.001 |
| Eczema nummulare | 37 (1.9) | 25 (2.8) | 12 (1.2) | 0.009 |
| Eczema infectiosum | 28 (1.5) | 21 (2.3) | 7 (0.7) | 0.002 |
| Contact eczema | 19 (1.0) | 2 (0.2) | 17 (1.6) | 0.002 |
| Eczema staticum | 15 (0.8) | 8 (0.9) | 7 (0.7) | 0.586 |
| Neurodermatitis | 35 (1.8) | 26 (2.9) | 9 (0.9) | <0.001 |
| Psoriasis | 40 (2.1) | 23 (2.6) | 17 (1.6) | 0.202 |
|
| 654 (33.9) | 629 (70.4) | 25 (2.4) | a)<0.001 |
| Alopecia areata | 7 (0.4) | 5 (0.6) | 2 (0.2) | 0.182 |
| Androgenetic alopecia | 627 (32.5) | 613 (68.6) | 14 (1.4) | <0.001 |
| Hyperhidrosis | 42 (2.2) | 32 (3.6) | 10 (1.0) | <0.001 |
|
| 81 (4.2) | 32 (3.6) | 49 (4.7) | 0.209 |
| Lichen ruber planus | 13 (0.7) | 8 (0.9) | 5 (0.5) | 0.270 |
| Dermatitis herpetiformis | 6 (0.3) | 2 (0.2) | 4 (0.4) | 0.523 |
| DLE | 1 (0.1) | 0 (0.0) | 1 (0.1) | 0.353 |
| SLE | 1 (0.1) | 0 (0.0) | 1 (0.1) | 0.353 |
| Vitiligo | 32 (1.7) | 10 (1.1) | 22 (2.1) | 0.085 |
| Urticaria | 10 (0.5) | 5 (0.6) | 5 (0.5) | 0.815 |
|
| 12 (0.6) | 7 (0.8) | 5 (0.5) | 0.403 |
| Melanoma | 1 (0.1) | 1 (0.1) | 0.0 (0) | 0.353 |
| Solar keratosis | 12 (0.6) | 7 (0.8) | 5 (0.5) | 0.403 |
| Basal cell carcinoma | 7 (0.4) | 2 (0.2) | 5 (0.5) | 0.346 |
*P-value for difference of prevalence between males and females evaluated using Pearson's Chi-Squared test or Fisher's Exact test.
All study cases had at least one pigmented naevus.
The effect of male sex to the prevalence of skin findings and diseases, compared to females.
| Unadjusted RRs | Adjusted | |||
| RR | 95% CI | aRR | 95% CI | |
|
| ||||
| Dermatofibroma | 0.66 | 0.55–0.78 | 0.66 | 0.55–0.79 |
| Cherry angioma | 0.81 | 0.75–0.87 | 0.81 | 0.75–0.88 |
| Seborrheic keratosis | 0.87 | 0.78–0.96 | 0.87 | 0.78–0.96 |
| Lentigo senilis | 0.61 | 0.48–0.77 | 0.61 | 0.48–0.77 |
| Lipoma | 2.38 | 1.40–4.02 | 2.40 | 1.42–4.06 |
| Naevus flammeus | 0.75 | 0.64–0.88 | 0.75 | 0.64–0.88 |
|
| 1.57 | 1.41–1.74 | 1.56 | 1.40–1.73 |
| Onychomycosis | 2.65 | 1.96–3.60 | 2.63 | 1.94–3.56 |
| Tinea pedis | 1.99 | 1.71–2.33 | 1.98 | 1.70–2.31 |
| Folliculitis | 3.32 | 2.21–4.98 | 3.27 | 2.18–4.91 |
|
| 0.80 | 0.69–0.93 | 0.79 | 0.68–0.92 |
| Acne scars | 1.40 | 1.07–1.84 | 1.39 | 1.06–1.83 |
| Rosacea | 0.55 | 0.44–0.69 | 0.54 | 0.43–0.68 |
| Erytematoteleangiectatic | 0.55 | 0.43–0.71 | 0.54 | 0.42 – 0.70 |
| Papulopustular | 0.42 | 0.22–0.81 | 0.42 | 0.22–0.81 |
| Perioraldermatitis | 0.09 | 0.01–0.68 | 0.09 | 0.01–0.70 |
|
| 1.28 | 1.11–1.48 | 1.28 | 1.10–1.48 |
| Atopic eczema | 0.70 | 0.46–1.05 | 0.70 | 0.47–1.06 |
| Hand eczema | 0.73 | 0.54–0.98 | 0.73 | 0.54–0.98 |
| Seborrheic eczema | 3.79 | 2.59–5.54 | 3.78 | 2.59–5.53 |
| Eczema nummulare | 2.41 | 1.22–4.77 | 2.37 | 1.21–4.67 |
| Eczema infectiosum | 3.47 | 1.48–8.13 | 3.36 | 1.43–7.86 |
| Contact eczema | 0.14 | 0.03–0.59 | 0.13 | 0.03–0.58 |
| Neurodermatitis | 3.34 | 1.58–7.10 | 3.36 | 1.59–7.10 |
|
| 29.16 | 19.75–43.04 | 29.13 | 19.73–43.02 |
| Androgenetic alopecia | 50.74 | 30.10–85.53 | 50.73 | 30.09–85.52 |
| Hyperhidrosis | 3.71 | 1.83–7.50 | 3.68 | 1.82–7.47 |
Abbrevations: RR, relative risk; aRR, adjusted relative risk; CI, confidence interval.
* Adjusted for education.